Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Myeloma.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 09 Feb 2010
At a glance
- Drugs Beta alethine (Primary)
- Indications Myeloma
- Focus Therapeutic Use
- 01 Oct 2005 New trial record.